Sequence
|
Vα 2.3
| |
9.11
|
---|
|
C
|
V
|
V
| |
D
|
Y
|
G
|
G
|
S
|
Q
|
G
|
N
|
---|
2.3 + 2.14 + 1.10
|
5′-TGT
|
GTG
|
GTG
|
—
|
GAT
|
TAT
|
GGA
|
GGA
|
AGC
|
CAA
|
GGA
|
AAT
|
2.30
|
5′-TGT
|
GTG
|
GTG
|
—
|
GAT
|
TAC
|
GGA
|
GGA
|
AGC
|
CAA
|
GGA
|
AAT
|
2.43
|
5′-TGT
|
GTG
|
GTG
|
—
|
GAT
|
TAC
|
GGA
|
GGA
|
AGC
|
CAG
|
GGA
|
AAT
|
|
C
|
V
|
V
| |
P
|
S
|
G
|
G
|
S
|
Q
|
G
|
N
|
2.8
|
5′-TGT
|
GTG
|
GTC
|
—
|
CCA
|
TCA
|
GGA
|
GGA
|
AGC
|
CAA
|
GGA
|
AAT
|
2.37
|
5′-TGT
|
GTG
|
GTC
|
—
|
CCA
|
TCA
|
GGA
|
GGG
|
AGC
|
CAA
|
GGA
|
AAT
|
- Nucleotides that alter between sequences are underlined. The identical sequences 2.3/2.14 and 1.10 are from two different patients (Patients 2 and 1, respectively). Note that the tyrosine (Y) at the second 5′ position of Jα 9.11, in the upper group of sequences, is substituted with a serine (S), with similar properties, in sequences 2.8 and 2.37.